MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with H

Hyoscine hydrobromide

Hyoscine hydrobromide 150microgram tablets

Compatible

Stability notes for Hyoscine hydrobromide 150microgram tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Kwells Kids 150microgram tablets (Dexcel-Pharma Ltd).

Supplier

Kwells Kids 150microgram tablets (Dexcel-Pharma Ltd)

Hyoscine hydrobromide 300microgram tablets

No stability information

Stability notes for Hyoscine hydrobromide 300microgram tablets

There are no stability notes for this medicine.

Suppliers

Kwells 300microgram tablets (Dexcel-Pharma Ltd)
Travel Calm 300microgram tablets (The Boots Company Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.